| Literature DB >> 29970130 |
Kristian D Friesgaard1,2, Ingunn S Riddervold3, Hans Kirkegaard3, Erika F Christensen4,5,6, Lone Nikolajsen7.
Abstract
BACKGROUND: Acute pain is a frequent symptom, but little is known about the frequency and causes of acute pain in the prehospital population. The objectives of this study were to investigate the frequency of moderate to severe pain among prehospital patients and the underlying causes according to primary hospital diagnose codes.Entities:
Keywords: Acute pain; Causes of acute pain; Prehospital
Mesh:
Substances:
Year: 2018 PMID: 29970130 PMCID: PMC6029421 DOI: 10.1186/s13049-018-0521-2
Source DB: PubMed Journal: Scand J Trauma Resusc Emerg Med ISSN: 1757-7241 Impact factor: 2.953
Fig. 1Flow diagram of included patients. Definition of pain on a numeric rating scale (NRS, 0–10) or 4-point verbal rating scale (VRS-4) upon initial patient triage. No or mild pain: NRS < 4 or less than moderate on VRS-4. Moderate to severe pain: NRS ≥ 4 or at least moderate on VRS-4
Fig. 2Distribution of pain within the 21 ICD-10 chapters. Definition of pain on a numeric rating scale (NRS, 0–10) or 4-point verbal rating scale (VRS-4) upon initial patient triage. No or mild pain: NRS < 4 or less than moderate on VRS-4. Moderate pain: NRS 4–6 or moderate on VRS-4. Severe pain: NRS ≥ 7 or severe on VRS-4. Abbreviation: ICD-10; 10th version of the International Classification of Diseases
Distribution of moderate to severe pain and frequency of fentanyl administration within the 21 ICD-10 chapters
| ICD-10 chapters | Total | Moderate to severe paina, b | Fentanyl adm.b | |||
|---|---|---|---|---|---|---|
|
| Yes (%) | No information (%) |
| Yes (%) | ||
| I | Infectious and parasitic diseases | 1108 | 22.0 (19.6–24.6) | 34.0 (31.2–36.9) | 32 | 2.9 (2.0–4.1) |
| II | In situ neoplasms | 444 | 21.6 (17.9–25.7) | 31.1 (26.8–35.6) | 17 | 3.8 (2.2–6.1) |
| III | Diseases of blood, blood-forming organs and certain disorders involving the immune mechanism | 219 | 18.3 (13.4–24.0) | 29.7 (23.7–36.2) | 13 | 5.9 (3.2–9.9) |
| IV | Endocrine, nutritional, and metabolic disease | 741 | 10.4 (8.3–12.8) | 34.4 (31.0–38.0) | 8 | 1.1 (0.5–2.1) |
| V | Mental and behavioral disorders | 968 | 8.3 (6.6–10.2) | 34.9 (31.9–38.0) | 5 | 0.5 (0.2–1.2) |
| VI | Diseases of the nervous system | 1153 | 13.6 (11.7–15.7) | 35.0 (32.3–37.9) | 16 | 1.4 (0.8–2.2) |
| VII | Diseases of the eye and adnexa | 24 | 20.8 (7.1–42.2) | 25.0 (9.8–46.7) | 0 | – |
| VIII | Diseases of the ear and mastoid process | 98 | 14.3 (8.0–22.8) | 29.6 (20.8–39.7) | 2 | 2.5 (0.2–7.2) |
| IX | Diseases of the circulatory system | 4812 | 22.1 (20.9–23.3) | 32.0 (30.7–33.4) | 356 | 7.4 (6.7–8.2) |
| X | Diseases of the respiratory system | 3467 | 14.2 (13.0–15.4) | 35.2 (33.7–36.9) | 88 | 2.5 (2.0–3.1) |
| XI | Diseases of the digestive system | 1999 | 40.7 (38.6–42.9) | 28.0 (26.1–30.0) | 224 | 11.2 (9.9–12.7) |
| XII | Diseases of skin and subcutaneous tissue | 96 | 12.5 (6.6–20.8) | 39.6 (29.7–50.1) | 0 | – |
| XIII | Diseases of the musculoskeletal system and connective tissue | 772 | 60.6 (57.0–64.1) | 23.1 (20.1–26.2) | 191 | 24.7 (21.7–27.9) |
| XIV | Diseases of the genitourinary system | 1105 | 33.5 (30.7–36.4) | 27.4 (24.8–30.2) | 124 | 11.2 (9.4–13.2) |
| XV | Pregnancy, childbirth, and the puerperium | 377 | 30.2 (25.6–35.1) | 39.3 (34.3–44.4) | 12 | 3.2 (1.7–5.5) |
| XVI | Certain conditions originating in the perinatal period | 0 | – | – | 0 | – |
| XVII | Congenital malformations, deformations, and chromosomal abnormalities | 10 | – | – | 0 | – |
| XVIII | Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified | 7101 | 28.5 (27.4–29.5) | 28.1 (27.0–29.1) | 355 | 5.0 (4.5–5.5) |
| XIX | Injury, poisoning, and certain other consequences of external causes | 8041 | 42.8 (41.7–43.9) | 28.8 (27.8–29.8) | 1456 | 18.1 (17.3–19.0) |
| XX | External causes of morbidity and mortality | 0 | – | – | – | |
| XXI | Factors influencing health status and contact with health services | 5148 | 31.6 (30.3–32.9) | 29.6 (28.4–30.9) | 364 | 7.1 (6.4–7.8) |
| – | Unknown | 3558 | 8.1 (7.2–9.0) | 51.3 (49.7–53.0) | 12 | 0.3 (0.2–0.6) |
| Total | 41,241 | 27.7 (27.3–28.2) | 32.2 (31.7–32.6) | 3275 | 7.9 (7.7–8.2) | |
Abbreviations: ICD-10 10th version of the international classification of diseases, Adm administration
aModerate to severe pain defined as a numeric rating scale ≥ 4 or moderate pain or higher registered on a 4-point verbal rating scale upon initial patient triage
bGiven as proportions (%) with 95% confidence intervals
Frequency of fentanyl administration among patients with moderate and severe pain
| ICD-10 chapters | Total | Moderatea, b | Fentanyl adm. | Severea, c | Fentanyl adm. | |
|---|---|---|---|---|---|---|
|
| % | % | ||||
| I | Infectious and parasitic diseases | 244 | 73.0 (66.9–78.4) | 8 (3.3) | 27.0 (21.6–33.1) | 21 (8.6) |
| II | In situ neoplasms | 96 | 63.0 (52.0–72.2) | 3 (3.1) | 37.0 (27.8–48.0) | 10 (10.4) |
| III | Diseases of blood, blood-forming organs and certain disorders involving the immune mechanism | 40 | 57.5 (40.9–73.0) | 1 (2.5) | 42.5 (27.0–59.1) | 11 (27.5) |
| IV | Endocrine, nutritional, and metabolic disease | 77 | 70.1 (58.6–80.0) | 2 (2.6) | 29.9 (20.0–41.3) | 5 (6.5) |
| V | Mental and behavioral disorders | 80 | 83.8 (73.8–91.1) | – | 16.2 (8.9–26.2) | 3 (3.8) |
| VI | Diseases of the nervous system | 157 | 63.7 (55.7–71.2) | 3 (1.9) | 36.3 (28.8–44.3) | 7 (4.5) |
| VII | Diseases of the eye and adnexa | 5 | 80.0 (28.4–99.5) | – | 20.0 (0.5–71.6) | – |
| VIII | Diseases of the ear and mastoid process | 14 | 64.3 (35.1–87.2) | – | 35.7 (12.8–64.9) | 2 (14.3) |
| IX | Diseases of the circulatory system | 1064 | 68.2 (65.3–71.0) | 111 (10.4) | 31.8 (29.0–34.7) | 156 (14.7) |
| X | Diseases of the respiratory system | 491 | 75.5 (70.4–78.3) | 16 (3.2) | 24.5 (21.7–29.6) | 48 (9.8) |
| XI | Diseases of the digestive system | 814 | 50.5 (47.0–54.0) | 39 (4.8) | 49.5 (46.0–53.0) | 167 (20.5) |
| XII | Diseases of skin and subcutaneous tissue | 12 | 83.3 (51.6–97.9) | – | 16.7 (2.1–48.4) | – |
| XIII | Diseases of the musculoskeletal system and connective tissue | 468 | 45.5 (40.9–50.1) | 38 (8.1) | 54.5 (49.9–59.1) | 145 (31.0) |
| XIV | Diseases of the genitourinary system | 370 | 53.0 (47.7–58.2) | 25 (6.8) | 47.0 (41.8–52.3) | 90 (24.3) |
| XV | Pregnancy, childbirth, and the puerperium | 114 | 59.6 (50.1–68.7) | 3 (2.6) | 40.4 (31.3–49.9) | 9 (7.9) |
| XVI | Certain conditions originating in the perinatal period | 0 | – | – | – | – |
| XVII | Congenital malformations, deformations, and chromosomal abnormalities | 3 | – | – | – | – |
| XVIII | Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified | 2022 | 63.1 (61.0–65.2) | 82 (4.1) | 36.9 (34.8–39.0) | 240 (11.9) |
| XIX | Injury, poisoning, and certain other consequences of external causes | 3442 | 59.6 (58.0–61.3) | 336 (10.0) | 40.4 (38.7–42.0) | 994 (28.9) |
| XX | External causes of morbidity and mortality | 0 | – | – | – | – |
| XXI | Factors influencing health status and contact with health services | 1630 | 69.8 (67.5–72.0) | 118 (7.2) | 30.2 (28.0–32.5) | 182 (11.2) |
| – | Unknown | 287 | 85.0 (80.4–88.9) | 2 (0.7) | 15.0 (11.1–19.6) | 8 (2.9) |
| Total | 11,430 | 27.7 (27.3–28.2) | 788 (6.9) | 32.2 (31.7–32.6) | 2098 (18.4) |
Abbreviations: ICD-10 10th version of the international classification of diseases, Adm administration
aGiven as proportions (%) with 95% confidence intervals
bModerate pain defined as a numeric rating scale 4–6 or moderate pain registered on a 4-point verbal rating scale upon initial patient triage
cSevere pain defined as a numeric rating scale ≥ 7 or severe pain registered on a 4-point verbal rating scale upon initial patient triage
Characteristics of patients according to pain status
| Moderate to severe paina, b | ||||
|---|---|---|---|---|
| Yes | No | No information | ||
| Agec | 54.4 (54.0–54.8) | 61.4 (61.1–61.8) | 58.7 (58.2–59.1) | |
| Male sexb | 46.9 (45.9–47.8) | 53.4 (52.7–54.2) | 51.9 (51.0–52.7) | |
| Comorbidityb | ||||
| 0 | 54.8 (53.9–55.7) | 40.8 (40.0–41.5) | 43.7 (42.9–44.5) | |
| 1 | 15.9 (15.2–16.6) | 20.1 (19.5–20.7) | 18.3 (19.5–20.7) | |
| 2 | 11.1 (10.5–11.7) | 13.4 (12.9–13.9) | 13.4 (12.8–13.9) | |
| 3+ | 18.2 (17.4–18.8) | 25.7 (25.0–26.4) | 24.6 (23.9–25.4) | |
| 30 day mortalityb | 2.8 (2.5–3.1) | 4.4 (4.1–4.7) | 5.8 (5.4–6.2) | |
| 112 emergency callb | 50.7 (49.7–51.6) | 47.0 (46.2–47.8) | 52.2 (51.3–53.0) | |
aModerate to severe pain defined as a numeric rating scale ≥ 4; or “moderate” pain or higher registered on a 4-point verbal rating scale upon initial patient triage
bGiven as proportions (%) with 95% confidence intervals
cGiven as mean with 95% confidence intervals